A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation

Abstract Detection of patients with esophageal squamous cell carcinoma (ESCC) who do not benefit from standard chemoradiation (CRT) is an important medical need. Radiomics using 18-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising approach. In this retrospective study of 184...

Full description

Bibliographic Details
Main Authors: Yimin Li, Marcus Beck, Tom Päßler, Chen Lili, Wu Hua, Ha Dong Mai, Holger Amthauer, Matthias Biebl, Peter C. Thuss-Patience, Jasmin Berger, Carmen Stromberger, Ingeborg Tinhofer, Jochen Kruppa, Volker Budach, Frank Hofheinz, Qin Lin, Sebastian Zschaeck
Format: Article
Language:English
Published: Nature Publishing Group 2020-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-74701-w

Internet

https://doi.org/10.1038/s41598-020-74701-w

Similar Items